Simon Lévy1, Rafael Heiss1, Robert Grimm2, David Grodzki2, Andreas Voskrebenzev3,4, Jens Vogel-Claussen3,4, Florian Fuchs5, Richard Strauss5, Susanne Achenbach6, Daniel Klett5, Jonas Schmid5, Andreas E. Kremer5,7, Michael Uder1, Armin M. Nagel1, and Sebastian Bickelhaupt1
1Institute of Radiology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany, 2MR Application Predevelopment, Siemens Healthcare, Erlangen, Germany, 3Institute of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany, 4Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany, 5Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany, 6Department of Transfusion Medicine and Haemostaseology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany, 7Department of Gastroenterology and Hepatology, University Hospital Zürich, Zürich, Switzerland
Synopsis
Free-breathing lung images were acquired at 0.55T in 73 Covid-19 patients, on average 5.4 months after the symptoms onset.
Perfusion, fractional ventilation and Flow-Volume Loop correlation (FVLc) maps
were extracted with the Phase-Resolved Functional Lung analysis technique, and percentages
of defect areas were calculated. The most relevant predictors of the presence
of persistent symptoms were the areas with concurrent perfusion and FVLc
defects, and the areas without defects. Patients could be classified as symptomatic or
asymptomatic with an accuracy of 71% when fitting a regression model with these
predictors on the entire dataset and their combined score was significantly
different.
Introduction
With the Covid-19 pandemic, diagnostic imaging of
the lungs has become crucial for the follow-up of the alterations incurred by
this infectious disease still to be fully characterized. The main technology
currently used remains Computed Tomography, which exposes the patient to
ionizing radiation, especially in repetitive examinations. In contrast, MRI is
a non-ionizing technology providing functional information beyond morphological
assessment, but is hampered in the lungs by susceptibility effects due to the
direct tissue-air interface, limiting its clinical use. However, these effects are
mitigated at lower field strengths, which are currently reconsidered by MRI
vendors in conjunction with the latest advances in sequence developments,
reconstruction and data processing (e.g., 0.55T)1. Moreover, free-breathing
analysis techniques based on Fourier-Decomposition such as PREFUL
(Phase-Resolved Functional Lung)2 can provide
quantitative maps of perfusion and ventilation functions, and identified significant
changes in defect areas in different pathologies2–5.
This study aimed to evaluate the potential of
free-breathing lung MRI at 0.55T in combination with the PREFUL technique for
the diagnostic and follow-up of long-Covid symptoms.Materials & Methods
Acquisition. A balanced steady-state
free precession sequence was optimized on a 0.55T prototype whole-body system
(Siemens Healthcare, Erlangen, Germany) for free-breathing lung imaging: one
two-dimensional coronal slice (middle of the heart), thickness=15mm, in-plane
resolution=1.7x1.7mm
2, matrix=128x128 (interpolated to 256x256), bandwidth=1302Hz/pixel, flip
angle=30°, TR/TE=276.7/1.6ms, GRAPPA=2, 250 time points, duration=1min34s. The
sequence was applied to 73 patients infected with Covid-19, 3.5-7.4 months
after the symptoms onset.
Processing. The following metrics
were automatically calculated voxel-wise with a prototype implementation of the PREFUL technique
2 (MR Lung v2.0, Siemens Healthcare), after
registration to a manually selected mid-expiration position:
- Normalized perfusion (Q, %) with respect
to full-blood signal (highest perfusion signal in-between the lungs3);
- Fractional ventilation (FV, %)6;
- Flow-Volume Loop correlation (FVLc)5: correlation of
the Flow-Volume Loop (deduced from the FV reconstructed cycle) with respect to
a healthy region (largest connected region within the 80th and 90th
FV percentiles);
- Perfusion time-to-peak (ms) with
respect to the normalization region;
- FV time-to-peak (% of the
respiratory cycle).
From
those maps, the percentage of defect areas (Q-Defect-Total, FV-Defect-Total,
FVLc-Defect-Total) was calculated based on thresholds optimized on a large
cohort (not published yet) of healthy volunteers and patients with various lung
diseases (perfusion: 2%, FV: 40% of the 90
th percentile, FVLc: 0.9).
The percentage of overlap between defect areas of perfusion and
ventilation metrics (Q-FV-Defect, Q-FVLc-Defect) and perfusion defects
exclusive to ventilation defects (Q-Defect-FV-Exclusive,
Q-Defect-FVLc-Exclusive) were derived, and vice versa (FV-Defect-Q-Exclusive,
FVLc-Defect-Q-Exclusive), in addition to areas without defect on both perfusion
and ventilation maps (Q-FV-Non-Defect, Q-FVLc-Non-Defect).
Analysis. Three patients were discarded because of signal clipping
in MR data, resulting in a final cohort of 70 patients (
Fig.1).
First, the variables with the highest predictive power for
the presence of persistent symptoms had to be determined. All MRI metrics
described above, sex, age, body mass index and the presence of
pre-existing conditions affecting baseline functions (e.g., asthma) were
included. These variables were standardized with respect to their
distribution in the cohort. For every number of variables N to
select, the Recursive Feature Elimination algorithm (scikit-learn 0.24.2) was applied
to evaluate the logistic regression model for the prediction of the presence of
persistent symptoms. A Repeated Stratified K-Fold cross-validation strategy was
used with 7 splits (6 folds for fitting, 1 for evaluation), repeated 5 times. The
mean classification accuracy was calculated across all splits and repetitions, for
each N.
Secondly, the set of
variables providing the highest mean accuracy was kept and the mean Receiver
Operating Characteristic curve was calculated with a Stratified K-Fold
cross-validation (7 folds).
Results
The animation in
Fig.2 shows the image time series obtained in two patients, without and
with persistent symptoms. The most relevant predictors (mean accuracy=67%) were
(in order of selection,
Fig.3):
- Q-FVLc-Defect
- Q-FVLc-Non-Defect.
The mean Area Under the Curve
(AUC) was 0.68 when evaluating the model with those variables only (
Fig.4). Fitting the model with these predictors on
the entire dataset yielded an AUC of 0.71 and an accuracy of 71%, with the respective
coefficients:
- $$$\alpha_1$$$=3.19 (without
standardization, $$$\alpha_1^{native}$$$=1.02)
- $$$\alpha_2$$$=1.59 ($$$\alpha_2^{native}$$$=0.09)
Discarding MRI
metrics, the sex was the best predictor (57% accuracy).
While no significant
difference in Q-FVLc-Defect and Q-FVLc-Non-Defect were observable between the
two groups (Student’s t-test p-value of 0.233 and 0.227, respectively), the
difference in the score
$$$\lambda=\alpha_1^{(native)}×$$$[Q-FVLc-Defect]$$$+\alpha_2^{(native)}×$$$[Q-FVLc-Non-Defect] was significant
(p-value<0.02). Clear functional abnormalities were observed at the
individual level comparing perfusion, FV and FVLc maps in the patients best
classified in each group by the model (
Fig.5).
Discussion
As in other pathologies5, FVLc, which captures
the ventilation cycle dynamics, was more sensitive than FV to the presence of
symptoms. The involvement of perfusion concurs with the main vascular component
of the disease previously reported7,8. The concurrent presence of perfusion and
ventilation dynamics defects/non-defects appeared as a discriminant factor between patients with and
without persistent symptoms. The score $$$\lambda$$$ could be a potential
biomarker for lung assessment in Covid-19 patients.Conclusion & Perspectives
Free-breathing 0.55T MRI and the PREFUL analysis demonstrated
sensitivity to the presence of persistent symptoms with an accuracy of 71%, concurrent perfusion and FVLc defects/non-defects being the most relevant factors. More advanced
models could increase this accuracy. An ongoing longitudinal study will aim to
confirm these findings.Acknowledgements
The authors would like to gratefully thank Siemens
Healthineers for the support in this study. This work received funding from the Bayerisches
Staatsministerium für Wissenschaft und Kunst.References
1. Heiss,
R., Nagel, A. M., Laun, F. B., Uder, M. & Bickelhaupt, S. Low-Field
Magnetic Resonance Imaging: A New Generation of Breakthrough Technology in
Clinical Imaging. Invest Radiol 56, 726–733 (2021).
2. Voskrebenzev,
A. et al. Feasibility of quantitative regional ventilation and perfusion
mapping with phase‐resolved functional lung (PREFUL) MRI in healthy volunteers
and COPD, CTEPH, and CF patients. Magn. Reson. Med 79, 2306–2314
(2018).
3. Behrendt,
L. et al. Validation of Automated Perfusion‐Weighted Phase‐Resolved
Functional Lung (PREFUL)‐MRI in Patients With Pulmonary Diseases. J. Magn.
Reson. Imaging 52, 103–114 (2020).
4. Pöhler,
G. H. et al. Chronic thromboembolic pulmonary hypertension perioperative
monitoring using phase‐resolved functional lung (PREFUL)‐MRI. J. Magn.
Reson. Imaging 52, 610–619 (2020).
5. Moher
Alsady, T. et al. MRI‐derived regional flow‐volume loop parameters
detect early‐stage chronic lung allograft dysfunction. J. Magn. Reson. Imaging
50, 1873–1882 (2019).
6. Klimeš,
F. et al. Free‐breathing quantification of regional ventilation derived
by phase‐resolved functional lung (PREFUL) MRI. NMR in Biomedicine 32,
e4088 (2019).
7. Siddiqi,
H. K., Libby, P. & Ridker, P. M. COVID-19 – A vascular disease. Trends
in Cardiovascular Medicine 31, 1–5 (2021).
8. Zamboni,
P. COVID-19 as a Vascular Disease: Lesson Learned from Imaging and Blood
Biomarkers. Diagnostics 10, 440 (2020).